Sign In | Not yet a member? | Submit your article
 
Home   Technical   Study   Novel   Nonfiction   Health   Tutorial   Entertainment   Business   Magazine   Arts & Design   Audiobooks & Video Training   Cultures & Languages   Family & Home   Law & Politics   Lyrics & Music   Software Related   eBook Torrents   Uncategorized  
Letters: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Innovation and Commercialisation in the Biopharmaceutical Industry: Creating and Capturing Value
Innovation and Commercialisation in the Biopharmaceutical Industry: Creating and Capturing Value
Date: 13 April 2011, 02:03

Free Download Now     Free register and download UseNet downloader, then you can FREE Download from UseNet.

    Download without Limit " Innovation and Commercialisation in the Biopharmaceutical Industry: Creating and Capturing Value " from UseNet for FREE!
Product Description: `The processes of discovery, testing and distribution of new medicines have undergone radical change in recent decades, from a focus on small molecule drugs to biomedicine and related technologies. Bruce Rasmussen very effectively draws upon modern theories of the firm, data analysis, and case studies to provide important insights into the consequences of this change. He offers convincing evidence that contradicts the widely-held view that the biopharmaceutical sector has not generated considerable economic value.'
- Frank R. Lichtenberg, Columbia University, US
`Bio- and pharmaceutical industry discovery is a distressed asset today. Why? Bruce Rasmussen's book is a timely and very informative work, building on rich data sources and extensive economic research, on a subject of concern to us all. Is medicine discovery in permanent decline? Are the biotechnology and traditional pharma groups on a collision course, will the traditional group absorb the new, will integration take place, will a new discovery model emerge? I commend Bruce's book to all who wish to understand what is happening.'
- David W. Anstice, Merck & Co., Inc.
This path-breaking book addresses the ongoing implications for traditional pharmaceutical companies and biopharmaceutical start-ups of the realignment of the industry knowledge-base. The theoretical approach draws on the modern theory of the firm and related ideas in order to better define the concept of the business model, which is employed to guide the case studies and empirical analysis in the book.
The author shows that while traditional pharmaceutical companies have successfully adjusted their business models to meet the challenges of biotechnology, biopharmaceutical start-ups have experienced more problems. Despite the poor financial performance of the vast majority of these firms, the biopharmaceutical sector as a whole has created significant value. However, this has been captured disproportionately by a handful of large, fully-integrated biopharmaceutical firms and, to a lesser extent, by the largest dozen pharmaceutical companies.
This highly focused book will be a captivating read for innovation and biopharmaceutical industry analysts, as well as advisers formulating policies to support the development of the biopharmaceutical sector. Academics working on innovation and biotechnology, as well as scientists engaged in research in the life sciences, will also find this book of particular interest.

DISCLAIMER:

This site does not store Innovation and Commercialisation in the Biopharmaceutical Industry: Creating and Capturing Value on its server. We only index and link to Innovation and Commercialisation in the Biopharmaceutical Industry: Creating and Capturing Value provided by other sites. Please contact the content providers to delete Innovation and Commercialisation in the Biopharmaceutical Industry: Creating and Capturing Value if any and email us, we'll remove relevant links or contents immediately.



Comments

Comments (0) All

Verify: Verify

    Sign In   Not yet a member?


Popular searches